Do serum hepcidin-25 levels correlate with oxidative stress in patients with chronic kidney disease not receiving dialysis?

Clinical Nephrology

Volumn 78, Issue 4, 2012, Pages 281-286

  Maruyama, Yukio ^a   Yokoyama, Keitaro ^a   Yamamoto, Hiroyasu ^a   Nakayama, Masaaki ^b   Hosoya, Tatsuo ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

8 hydroxy 2'; Anemia of chronic disease (ACD); Deoxyguanosine (8 OHdG); Estimated glomerular filtration rate (eGFR); Ferritin; High sensitive C reactive protein (hsCRP)

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; HEPCIDIN; HEPCIDIN 25; TRANSFERRIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS;

ADULT; AGED; ANTIMICROBIAL CATIONIC PEPTIDES; C-REACTIVE PROTEIN; CHRONIC DISEASE; DEOXYGUANOSINE; ERYTHROPOIETIN; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS;

EID: 84867689566     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107424     Document Type: Article

References (23)

1. Langston RD, Presley R, Flanders WD, McClellan WM. Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction. Kidney Int. 2003; 64: 1398-1405.
2. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005; 352: 1011-1023.
3. Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Acta Haematol. 2009; 122: 78-86.
4. Babitt JL, Lin HY. Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD. Am J Kidney Dis. 2010; 55: 726-741.
5. Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, Taube DH, Bloom SR, Tam FW, Chapman RS, Maxwell PH, Choi P. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int. 2009; 75: 976-981.
6. Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, Salusky IB. Hepcidin - a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol. 2009; 4: 1051-1056.
7. Peters HP, Laarakkers CM, Swinkels DW, Wetzels JF. Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate. Nephrol Dial Transplant. 2010; 25: 848-853.
8. Tomosugi N, Kawabata H, Wakatabe R, Higuchi M, Yamaya H, Umehara H, Ishikawa I. Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. Blood. 2006; 108: 1381-1387.
9. Siems W, Quast S, Carluccio F, Wiswedel I, Hirsch D, Augustin W, Kraemer K, Hampl H, Sommerburg O. Oxidative stress in cardio renal anemia syndrome: correlations and therapeutic possibilities. Clin Nephrol. 2003; 60 (Suppl 1): S22-S30.
10. Kalantar-Zadeh K, Kalantar-Zadeh K, Lee GH. The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease? Clin J Am Soc Nephrol. 2006; 1 (Suppl 1): S9-S18.
11. El-Zein RA, Monroy CM, Cortes A, Spitz MR, Greisinger A, Etzel CJ. Rapid method for determination of DNA repair capacity in human peripheral blood lymphocytes amongst smokers. BMC Cancer. 2010; 10: 439.
12. Tarng DC, Huang TP, Wei YH, Liu TY, Chen HW, Wen Chen T, Yang WC. 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis. 2000; 36: 934-944.
13. Maruyama Y, Nakayama M, Yoshimura K, Nakano H, Yamamoto H, Yokoyama K, Lindholm B. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'- deoxyguanosine levels. Nephrol Dial Transplant. 2007; 22: 1407-1412.
14. Harrison-Findik DD, Schafer D, Klein E, Timchenko NA, Kulaksiz H, Clemens D, Fein E, Andriopoulos B, Pantopoulos K, Gollan J. Alcohol metabolism- mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem. 2006; 281: 22974-22982.
15. Ando Y, Ito S, Uemura O, Kato T, Kimura G, Nakao T, Hattori M, Fukagawa M, Horio M, Mitarai T. Japanese Society of Nephrology. CKD Clinical Practice Guidebook. The essence of treatment for CKD patients. Clin Exp Nephrol. 2009; 13: 191-248.
16. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009; 53: 982-992.
17. Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K, Hiai H, Ochi H, Osawa T. Quantitative immunohistochemical determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate- induced renal carcinogenesis model. Lab Invest. 1997; 76: 365-374.
18. Yilmaz MI, Carrero JJ, Axelsson J, Lindholm B, Stenvinkel P. Low-grade inflammation in chronic kidney disease patients before the start of renal replacement therapy: sources and consequences. Clin Nephrol. 2007; 68: 1-9.
19. Kulaksiz H, Theilig F, Bachmann S, Gehrke SG, Rost D, Janetzko A, Cetin Y, Stremmel W. The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol. 2005; 184: 361-370.
20. Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis. 2001; 37: 564-572.
21. Drueke T, Witko-Sarsat V, Massy Z, Descamps- Latscha B, Guerin AP, Marchais SJ, Gausson V, London GM. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation. 2002; 106: 2212-2217.
22. Bridges KR, Hoffman KE. The effects of ascorbic acid on the intracellular metabolism of iron and ferritin. J Biol Chem. 1986; 261: 14273-14277. PubMed
23. Lopez-Gomez JM, Portoles JM, Aljama P. Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality. Kidney Int Suppl. 2008; 74: S75-S81. doi:10.1038/ki.2008.523 PubMed